Thursday, November 5, 2026

BTC $75,877 ▼ 5.52%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$75,877−5.52%ETH$2,252−7.11%SOL$89.63−6.43%XRP$1.24−5.49%LINK$10.66−7.50%ADA$0.182−7.67%S&P 5007,417−3.53%Nasdaq24,532−4.68%Dow51,890−2.75%RUT2,748−3.82%TNX4.84%−1.04%TYX5.26%−0.49%FVX4.62%−1.47%IRX4.00%−0.62%VIX24.70+48.71%GOLD$4,126.00+1.30%SILVER$52.61+0.62%OIL$90.53+2.73%DXY101.45−0.11%NVDA$184.50−7.81%AAPL$344.40−1.46%TSLA$342.40−11.11%META$605.90−3.83%MSFT$540.64−2.73%AMZN$261.90−1.55%GOOGL$285.76−1.10%Fear & Greed50 — NeutralBTC$75,877−5.52%ETH$2,252−7.11%SOL$89.63−6.43%XRP$1.24−5.49%LINK$10.66−7.50%ADA$0.182−7.67%S&P 5007,417−3.53%Nasdaq24,532−4.68%Dow51,890−2.75%RUT2,748−3.82%TNX4.84%−1.04%TYX5.26%−0.49%FVX4.62%−1.47%IRX4.00%−0.62%VIX24.70+48.71%GOLD$4,126.00+1.30%SILVER$52.61+0.62%OIL$90.53+2.73%DXY101.45−0.11%NVDA$184.50−7.81%AAPL$344.40−1.46%TSLA$342.40−11.11%META$605.90−3.83%MSFT$540.64−2.73%AMZN$261.90−1.55%GOOGL$285.76−1.10%Fear & Greed50 — Neutral

Tag

argenx

1 article

U.S. Equities40d ago

Argenx's Vyvgart Franchise Offers 23% Upside; Four Studies Coming

The biotech reported 60% year-over-year revenue growth in Q2 2026 on gMG and CIDP therapies, with Wall Street's consensus target at $1,180.25.